Patent: 5,462,873
✉ Email this page to a colleague
Summary for Patent: 5,462,873
Title: | DNA for use in a simple method for detecting inhibitors of retrotransposition |
Abstract: | The present invention relates, in general, to a DNA segment. In particular, the present invention relates to a DNA segment comprising a selectable marker gene, a DNA segment comprising a selectable marker gene inserted into a retrotransposon, cells containing these DNA segments, and methods of using these DNA segments and cells. |
Inventor(s): | Garfinkel; David J. (Frederick, MD), Curcio; M. Joan (Keedysville, MD) |
Assignee: | The United States of America as represented by the Department of Health (Washington, DC) |
Application Number: | 08/102,854 |
Patent Claims: | see list of patent claims |
Details for Patent 5,462,873
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2012-10-31 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2012-10-31 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2012-10-31 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |